A possible antiatherogenic role for phosphocitrate through modulation of low density lipoprotein uptake and degradation in aortic smooth muscle cells
- 1 May 1987
- journal article
- research article
- Published by Elsevier in Atherosclerosis
- Vol. 65 (1-2) , 117-124
- https://doi.org/10.1016/0021-9150(87)90013-x
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- AtherogenesisAtherosclerosis, 1986
- Receptor-Mediated Endocytosis: Concepts Emerging from the LDL Receptor SystemAnnual Review of Cell Biology, 1985
- Phosphocitrate inhibition of 45 Ca 2+ uptake in rat aortic smooth muscle cells in primary cultureBiochemical and Biophysical Research Communications, 1985
- Metabolism of atherogenic lipoproteins by smooth muscle cells of different phenotype in culture.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1985
- Modification of experimental atherosclerosis by calcium-channel blockersThe American Journal of Cardiology, 1985
- Atherosclerosis: An overviewDrug Development Research, 1985
- New approaches in the treatment of atherosclerosisDrug Development Research, 1985
- Phosphocitrate and its analogue N-sulpho-2-amino tricarballylate inhibit aortic calcificationAtherosclerosis, 1984
- Atherosclerosis: Prevention by Agents Not Affecting Abnormal Levels of Blood LipidsScience, 1981
- Uptake and degradation of low density lipoprotein by swine arterial smooth muscle cells with inhibition of cholesterol biosynthesisBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1976